Kelly Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-137
| Closed | -$13.1K | – | 811 |
|
|
2024
Q1 | $13.1K | Buy |
137
+125
| +1,042% | +$11.9K | 0.01% | 382 |
|
|
2023
Q4 | $915 | Hold |
12
| – | – | ﹤0.01% | 658 |
|
|
2023
Q3 | $831 | Hold |
12
| – | – | ﹤0.01% | 645 |
|
|
2023
Q2 | $1.13K | Hold |
12
| – | – | ﹤0.01% | 593 |
|
|
2023
Q1 | $993 | Sell |
12
-12
| -50% | -$993 | ﹤0.01% | 591 |
|
|
2022
Q4 | $1.79K | Hold |
24
| – | – | ﹤0.01% | 517 |
|
|
2022
Q3 | $1.98K | Hold |
24
| – | – | ﹤0.01% | 508 |
|
|
2022
Q2 | $2.28K | Hold |
24
| – | – | ﹤0.01% | 485 |
|
|
2022
Q1 | $2.83K | Hold |
24
| – | – | ﹤0.01% | 493 |
|
|
2021
Q4 | $3.11K | Sell |
24
-23
| -49% | -$2.98K | ﹤0.01% | 491 |
|
|
2021
Q3 | $5.32K | Sell |
47
-4,821
| -99% | -$546K | ﹤0.01% | 408 |
|
|
2021
Q2 | $47K | Buy |
4,868
+4,821
| +10,257% | +$46.5K | ﹤0.01% | 466 |
|
|
2021
Q1 | $3.93K | Buy |
47
+14
| +42% | +$1.17K | ﹤0.01% | 436 |
|
|
2020
Q4 | $3.01K | Hold |
33
| – | – | ﹤0.01% | 426 |
|
|
2020
Q3 | $2.63K | Hold |
33
| – | – | ﹤0.01% | 407 |
|
|
2020
Q2 | $2.28K | Hold |
33
| – | – | ﹤0.01% | 416 |
|
|
2020
Q1 | $2.08K | Buy |
+33
| New | +$2.08K | ﹤0.01% | 386 |
|